The Surprising Thing Most of 2014's Top 10 Stocks Have in Common
8 out of 10 of last year's best-performing stocks have this one important common denominator.
3 Biotech Stocks That Could Trounce Gilead Sciences, Inc. in 2015
Gilead Sciences may look cheap, but three of our top analysts believe these three other biotech stocks could have an even better 2015.
Does This Drug Offer Exelixis Inc. Investors Hope for the Future?
A potential approval of Exelixis' cobimetinib in 2015 could help restore investors' confidence -- but risk remains.
3 Biotech Stocks That Could Double in 2015
Three Motley Fool contributors tell us which biotech stocks they think could make a big move next year.
3 Clinical Stage Biotech Stocks That Should Be on Your Watchlist in 2015
Three Motley Fool analysts tell us which emerging biotechnology stocks they're watching in 2015.